Royle, K., Coulson, A. B., Ramasamy, K., Cairns, D. A., Hockaday, A., Quezada, S., Drayson, M., Kaiser, M., Owen, R., Auner, H. W., Cook, G., Meads, D., Olivier, C., Barnard, L., Lambkin, R., Paterson, A., Dawkins, B., Chapman, M., Pratt, G., Popat, R., Jackson, G., Bygrave, C., Sive, J., de Tute, R., Chantry, A., Parrish, C., Cook, M., Asher, S., & Yong, K. (2022). risk and response adapted therapy following autologous stem cell transplant in patients with newly diagnosed multiple myeloma (RADAR (UK-MRA Myeloma XV Trial): study protocol for a phase II/III randomised controlled trial. BMJ open, 12(11), . http://access.bl.uk/ark:/81055/vdc_100169753504.0x000022